150 related articles for article (PubMed ID: 21802447)
1. Aprotinin and similar protease inhibitors as drugs against influenza.
Zhirnov OP; Klenk HD; Wright PF
Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
[TBL] [Abstract][Full Text] [Related]
2. Airway proteases: an emerging drug target for influenza and other respiratory virus infections.
Laporte M; Naesens L
Curr Opin Virol; 2017 Jun; 24():16-24. PubMed ID: 28414992
[TBL] [Abstract][Full Text] [Related]
3. A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site.
Straus MR; Whittaker GR
PLoS One; 2017; 12(3):e0174827. PubMed ID: 28358853
[TBL] [Abstract][Full Text] [Related]
4. The past, present and future of RNA respiratory viruses: influenza and coronaviruses.
Makarov V; Riabova O; Ekins S; Pluzhnikov N; Chepur S
Pathog Dis; 2020 Oct; 78(7):. PubMed ID: 32860686
[TBL] [Abstract][Full Text] [Related]
5. Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication.
Colombo É; Désilets A; Hassanzadeh M; Lemieux G; Marois I; Cliche D; Delbrouck JA; Murza A; Jean F; Marsault E; Richter MV; Leduc R; Boudreault PL
ChemMedChem; 2024 Jan; 19(2):e202300458. PubMed ID: 37864572
[TBL] [Abstract][Full Text] [Related]
6. Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin.
Wright ZVF; Wu NC; Kadam RU; Wilson IA; Wolan DW
Bioorg Med Chem Lett; 2017 Aug; 27(16):3744-3748. PubMed ID: 28689973
[TBL] [Abstract][Full Text] [Related]
7. Application of Super-Resolution and Advanced Quantitative Microscopy to the Spatio-Temporal Analysis of Influenza Virus Replication.
Touizer E; Sieben C; Henriques R; Marsh M; Laine RF
Viruses; 2021 Feb; 13(2):. PubMed ID: 33540739
[TBL] [Abstract][Full Text] [Related]
8. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Shimotai Y; Hatachi Y; Lusamba Kalonji N; Tando Y; Kitajima Y; Matsuo K; Kubo H; Nagatomi R; Hongo S; Homma M; Nishimura H
Pulm Pharmacol Ther; 2015 Aug; 33():66-74. PubMed ID: 26166259
[TBL] [Abstract][Full Text] [Related]
9. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
Meyer D; Sielaff F; Hammami M; Böttcher-Friebertshäuser E; Garten W; Steinmetzer T
Biochem J; 2013 Jun; 452(2):331-43. PubMed ID: 23527573
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
Bestle D; Heindl MR; Limburg H; Van Lam van T; Pilgram O; Moulton H; Stein DA; Hardes K; Eickmann M; Dolnik O; Rohde C; Klenk HD; Garten W; Steinmetzer T; Böttcher-Friebertshäuser E
Life Sci Alliance; 2020 Sep; 3(9):. PubMed ID: 32703818
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses.
Lee MG; Kim KH; Park KY; Kim JS
Arch Virol; 1996; 141(10):1979-89. PubMed ID: 8920829
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
13. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.
Shen LW; Mao HJ; Wu YL; Tanaka Y; Zhang W
Biochimie; 2017 Nov; 142():1-10. PubMed ID: 28778717
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin Inhibits SARS-CoV-2 Replication.
Bojkova D; Bechtel M; McLaughlin KM; McGreig JE; Klann K; Bellinghausen C; Rohde G; Jonigk D; Braubach P; Ciesek S; Münch C; Wass MN; Michaelis M; Cinatl J
Cells; 2020 Oct; 9(11):. PubMed ID: 33143316
[TBL] [Abstract][Full Text] [Related]
15. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
Böttcher-Friebertshäuser E; Klenk HD; Garten W
Pathog Dis; 2013 Nov; 69(2):87-100. PubMed ID: 23821437
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
Bogomolov P; Alexandrov A; Voronkova N; Macievich M; Kokina K; Petrachenkova M; Lehr T; Lempp FA; Wedemeyer H; Haag M; Schwab M; Haefeli WE; Blank A; Urban S
J Hepatol; 2016 Sep; 65(3):490-8. PubMed ID: 27132170
[TBL] [Abstract][Full Text] [Related]
17. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
Franco EJ; Pires de Mello CP; Brown AN
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
[TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in antiviral responses to dengue infection.
Wong RR; Abd-Aziz N; Affendi S; Poh CL
J Biomed Sci; 2020 Jan; 27(1):4. PubMed ID: 31898495
[TBL] [Abstract][Full Text] [Related]
19. Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti.
Dong S; Kang S; Dimopoulos G
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007681. PubMed ID: 31430351
[TBL] [Abstract][Full Text] [Related]
20. Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.
LeCher JC; Diep N; Krug PW; Hilliard JK
Viruses; 2019 May; 11(6):. PubMed ID: 31159175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
